SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2023 quarter moved down -53.32% to Rs. 1269.72 millions as compared to Rs. 2719.82 millions during the year ago period.The Net Loss for the quarter ended March 2023 is Rs. -49.96 millions as compared to Net Profit of Rs. 430.42 millions of corresponding quarter ended March 2022The Operating Profit of the company witnessed a decrease to 79.69 millions from 722.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1269.72 2719.82 -53.32 6281.66 6765.66 -7.15 6281.66 6765.66 -7.15
Other Income 25.66 68.00 -62.26 130.36 104.63 24.59 130.36 104.63 24.59
PBIDT 79.69 722.63 -88.97 893.00 1645.47 -45.73 893.00 1645.47 -45.73
Interest 64.05 33.30 92.34 207.40 90.90 128.16 207.40 90.90 128.16
PBDT 15.64 689.33 -97.73 685.60 1554.57 -55.90 685.60 1554.57 -55.90
Depreciation 77.75 106.56 -27.04 337.12 344.16 -2.05 337.12 344.16 -2.05
PBT -62.11 582.77 -110.66 348.48 1210.41 -71.21 348.48 1210.41 -71.21
TAX -12.15 152.35 -107.98 93.29 312.23 -70.12 93.29 312.23 -70.12
Deferred Tax -1.91 16.89 -111.31 93.29 26.10 257.43 93.29 26.10 257.43
PAT -49.96 430.42 -111.61 255.19 898.18 -71.59 255.19 898.18 -71.59
Equity 196.06 195.98 0.04 196.06 195.98 0.04 196.06 195.98 0.04
PBIDTM(%) 6.28 26.57 -76.38 14.22 24.32 -41.55 14.22 24.32 -41.55

Astec Lifesciences Share Price

707.35 -19.15 (-2.64%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×